T. Rowe Price Associates’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $9K | Sell |
|
|||||
|
2023
Q2 | $139K | Sell |
|
|||||
|
2023
Q1 | $357K | Hold |
|
|||||
|
2022
Q4 | $177K | Hold |
|
|||||
|
2022
Q3 | $478K | Buy |
|
|||||
|
2022
Q2 | $257K | Hold |
|
|||||
|
2022
Q1 | $312K | Hold |
|
|||||
|
2021
Q4 | $372K | Hold |
|
|||||
|
2021
Q3 | $307K | Hold |
|
|||||
|
2021
Q2 | $353K | Sell |
|
|||||
|
2021
Q1 | $468K | Buy |
|
|||||
|
2020
Q4 | $99K | Buy |
|
|||||
|
2020
Q3 | $178K | Buy |
|